EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC-ND 4.0

Post protocol residual thickness as a negative predictor for pharmacological treatment in early pregnancy loss

Ravit Pertez-Machluf, Maya Kimhi, Rotem Yedidia Moser, David Rosen, Yair Daykan, Ron Schonman, Zvi Klein, Yael Yagur iD

International Journal of Gynecology & Obstetrics · 2026

DOI: 10.1002/ijgo.70750 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift International Journal of Gynecology & Obstetrics, 2026. Verfasst von Ravit Pertez-Machluf und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, Israel. Hauptthemen laut MEDLINE: Misoprostol, Mifepristone, Abortion, Spontaneous. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine the rate of pharmacological treatment failure in early pregnancy loss, assess post‐treatment residua thickness as a predictor of retained products of conception (RPOC), identify a clinically relevant cutoff, and evaluate additional clinical and sonographic predictors.

Methods

This retrospective cohort study was conducted at a tertiary medical center and included patients treated with mifepristone–misoprostol for first‐trimester pregnancy loss between January 2019 and January 2022. Treatment success was assessed via transvaginal ultrasound, with residua thickness measured 14 days post‐treatment. The primary outcome was failure, defined as histologically confirmed RPOC following hysteroscopy. Secondary analyses evaluated clinical and sonographic predictors, focusing on post‐treatment residual thickness. Statistical analysis included receiver operating characteristic (ROC) curve assessment and multivariable logistic regression.

Results

Of the 717 patients included, 537 (74.9%) achieved successful medical management without further intervention, while 180 (25.1%) required intervention. Treatment failure was associated with greater post‐treatment residua thickness (mean 19.1 ± 9.1 mm vs. 10.4 ± 6.7 mm, P < 0.001). Residua thickness was an independent predictor of failure (adjusted odds ratio [aOR] 1.17, 95% confidence interval [CI]: 1.13–1.21, P < 0.001). ROC analysis identified an optimal cutoff of 14.9 mm, yielding 70% sensitivity and 81% specificity (area under the curve [AUC]: 0.835, 95% CI: 0.80–0.87) for predicting the need for surgical intervention.

Conclusion

Post‐treatment residual thickness is a significant predictor of pharmacological treatment failure in early pregnancy loss, with a clinically relevant cutoff of approximately 15 mm. Histologic validation provides a promising framework for refining management protocols, emphasizing the need for further studies to establish robust predictive criteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MisoprostolMifepristoneAbortion, SpontaneousHumansFemalePregnancyRetrospective StudiesAdultPregnancy Trimester, FirstTreatment FailureROC CurveUltrasonography

Stichwörter der Autor:innen

early pregnancy losspharmacological managementpredictive factorsretained products of conception (RPOC)treatment failure

Substanzen

MisoprostolMifepristone

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, Israel.
  • School of Medicine, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Sydney Women's Endosurgery Centre (SWEC), St George Hospital, Sydney, New South Wales, Australia.
  • University of New South Wales, Sydney, New South Wales, Australia.
  • Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel.

ORCID-Profile: Yael Yagur

Zitieren

APA

Pertez-Machluf, R., Kimhi, M., Yedidia Moser, R., Rosen, D., Daykan, Y., Schonman, R., Klein, Z., & Yagur, Y. (2026). Post protocol residual thickness as a negative predictor for pharmacological treatment in early pregnancy loss. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70750

Vancouver

Pertez-Machluf R, Kimhi M, Yedidia Moser R, Rosen D, Daykan Y, Schonman R, et al. Post protocol residual thickness as a negative predictor for pharmacological treatment in early pregnancy loss. International Journal of Gynecology & Obstetrics. 2026. doi:10.1002/ijgo.70750

BibTeX
@article{PertezMachluf2026,
  author = {Pertez-Machluf, Ravit and Kimhi, Maya and Yedidia Moser, Rotem and Rosen, David and Daykan, Yair and Schonman, Ron and Klein, Zvi and Yagur, Yael},
  title = {Post protocol residual thickness as a negative predictor for pharmacological treatment in early pregnancy loss},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2026},
  doi = {10.1002/ijgo.70750}
}
Kostenlos starten →